Sales & Marketing News | pharmaphorum

News

Rumour mill says AstraZeneca may be eyeing a takeover of Mer...

AstraZeneca is rumoured to be considering a bid to take control of its longstanding partner Mereo BioPharma, according to a

News

Mallinckrodt tries again with kidney drug terlipressin

Manufacturing problems wreaked havoc with Mallinckrodt's first attempt to secure FDA approval of its treatment candidate terlipressin for hepatorenal syndrome (HRS), but the drugmaker is ha

News

Lilly's Olumiant okayed in alopecia, with Pfizer, Concert in...

Eli Lilly and Incyte's Olumiant has secured the first FDA approval for a systemic drug to treat alopecia areata, an autoimmune condition causing patchy hair loss that affects more than 700,

News

Alnylam grabs FDA approval for its second amyloidosis therap...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler, mo

News

Tablets on dollar bills (treatment, addiction, aging - concept). Vintage effect.

FTC launches probe into pharmacy benefit management sector

Longstanding claims that one of the reasons for high drug prices in the US is the actions of pharmacy benefit management (PBM) companies – the middlemen in the supply chain – are being form

News

Eversana aims athletes' mental coaching at pharma sales reps

Eversana's suite of commercialisation tools for pharma companies will soon have a new component – cognitive behavioural training tools designed to improve the performance of sales represent

Rumour mill says AstraZeneca may be eyeing a takeover of Mer...

Mallinckrodt tries again with kidney drug terlipressin

Lilly's Olumiant okayed in alopecia, with Pfizer, Concert in...

Alnylam grabs FDA approval for its second amyloidosis therap...

FTC launches probe into pharmacy benefit management sector

Eversana aims athletes' mental coaching at pharma sales reps

FDA kicks off review of Takeda's narcolepsy hopeful

How to meet your physicians where they are online

News

Editor's Picks